Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.
about
Erythropoietin in ophthalmology: A literature reviewErythropoietin Pathway: A Potential Target for the Treatment of DepressionIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesErythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke.A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxiaAge-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietin.Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.Erythropoietin accelerates functional recovery after peripheral nerve injury.Does erythropoietin protect the preterm brain?Phylogenomic analyses reveal a molecular signature linked to subterranean adaptation in rodentsErythropoietin: still on the neuroprotection roadRole of erythropoietin in the brainErythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.A randomized, masked study of weekly erythropoietin dosing in preterm infantsWhite matter changes in patients with friedreich ataxia after treatment with erythropoietin.Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia.Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized EffectsEffect of erythropoietin on the expression of HIF-1 and iNOS in retina in chronic ocular hypertension rats.Effect of Erythropoietin on Serum Brain-derived Biomarkers after Carbon Monoxide Poisoning in Rats.Erythropoietin accelerates functional recovery after moderate sciatic nerve crush injury.Therapeutic time window for the effects of erythropoietin on astrogliosis and neurite outgrowth in an in vitro model of spinal cord injury.
P2860
Q26744850-6C41D28A-01DE-4286-AD6A-933EDB53463DQ26750850-EFF93EF8-2398-4498-B0DA-483B00CA4B6FQ28388335-4C0BBFE0-3FB5-4B76-A3FA-8BD901440D39Q33787770-8E2F7225-6AAD-4555-94A3-E16A28B32B4EQ34285714-D5A776AC-E9FF-4AF2-9704-E33F33EB80E1Q35017110-4EB36F00-A787-4436-AF78-0C29FAC4867AQ35471285-3C0D72AF-8EF1-48FE-ABF5-1422970D58B2Q35750138-A9D23AEA-AD26-4055-AEDD-D3846B45F881Q35813472-EF94BAA5-6F59-49CE-BE62-6A32419D3AC3Q35873085-2F478338-6069-4015-A848-C8BE11438865Q35949322-FB2FEE97-8E44-4EA9-96EC-30FC4B6EBE3CQ36153802-4D1E9A90-F4BC-4DC5-927F-BE314DEE186EQ36277628-433B7D58-E974-4523-A51A-E09EB8DDBCD9Q36624171-7D0E0049-DDAF-484F-A3C2-9BA21D158781Q36687686-3C17D43F-2F39-4703-8425-6B628FB0459EQ37631730-6750EED3-0BAE-4B50-A4D2-2885FD63F4D1Q41203727-C0637014-B9CC-4E42-98E0-F3C506D3AAB3Q41648362-9E959980-1767-442A-B1AE-0BE61EA2ADC6Q41960788-007AFE0E-9765-4EEA-8B92-252AC89FF80FQ43236616-A32ED33F-7119-469A-BEC8-8FAC653123E0Q51149238-893522DB-8EBF-48BA-A4D0-22D99ED4B7E2Q54123946-00EBC8B8-0F8A-4C72-9439-D4A4EC49281F
P2860
Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@ast
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@en
type
label
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@ast
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@en
prefLabel
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@ast
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@en
P1476
Erythropoietin in the central ...... hypoxic-ischemic brain damage.
@en
P2093
P577
2002-01-01T00:00:00Z